Status:
COMPLETED
Atrial Fibrillation Ablation
Lead Sponsor:
University of Campania Luigi Vanvitelli
Conditions:
Atrial Fibrillation
Heart Failure, Diastolic
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Objective. Atrial fibrillation (AF) recurrence after catheter ablation (CA) is a relevant clinical problem. Methods. 123 patients with paroxysmal AF will be identified and screened for participation ...
Detailed Description
Catheter ablation (CA) is first class treatment to restore sinus rhythm in patients with paroxysmal, symptomatic, drug refractory atrial fibrillation (AF). The sinus rhythm restoration after a success...
Eligibility Criteria
Inclusion
- aged more than 18,
- aged less than 75;
- clinical diagnosis of paroxysmal atrial fibrillation (AF)
- clinical diagnosis of symptomatic and anty- arrhythmic drugs refractory (AF)
- echocardiographic diagnosis of normal left atrium volumetry (left atrium volume \< 30 ml/mq)
- echocardiographic diagnosis of normal left ventricle ejection fraction (LVEF) (LVEF \> 55%).
Exclusion
- aged less than 18,
- aged more than 75;
- clinical diagnosis of not paroxysmal AF;
- clinical diagnosis of heart failure;
- echocardiographic diagnosis of left atrium dilatation (left atrium volume \> 30 ml/mq);
- echocardiographic diagnosis of LVEF depression (LVEF \<55%).
Key Trial Info
Start Date :
January 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2017
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT03410966
Start Date
January 1 2013
End Date
November 1 2017
Last Update
January 26 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Raffaele Marfella
Naples, Italy, 80128